SAMANTHA RELYEA: Open Payments
NPI 1164957072 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 26 payments from 10 companies in 2025. Trend: 2023 $80 · 2024 $182 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $223 |
| Lilly USA, LLC | 6 | $140 |
| ABBVIE INC. | 4 | $82 |
| Novo Nordisk Inc | 3 | $50 |
| Exact Sciences Corporation | 2 | $49 |
| Amgen Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Renalytix AI, Inc. | 1 | $19 |
| Amphastar Pharmaceuticals, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: AIRSUPRA, MOUNJARO, Cologuard Collection Kit, VRAYLAR, Wegovy, ZEPBOUND, QULIPTA, EVENITY.
Industry payments across NY — which companies pay providers there.
